Gayatri BioOrganics Ltd
BSE:524564
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gayatri BioOrganics Ltd
BSE:524564
|
IN |
|
Tarini International Ltd
BSE:538496
|
IN |
Balance Sheet
Balance Sheet Decomposition
Gayatri BioOrganics Ltd
Gayatri BioOrganics Ltd
Balance Sheet
Gayatri BioOrganics Ltd
| Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
14
|
22
|
7
|
17
|
185
|
15
|
21
|
24
|
20
|
20
|
0
|
0
|
2
|
10
|
4
|
0
|
0
|
0
|
0
|
|
| Cash |
14
|
22
|
7
|
17
|
185
|
15
|
21
|
24
|
20
|
12
|
0
|
0
|
2
|
10
|
4
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
30
|
42
|
87
|
102
|
190
|
288
|
498
|
987
|
493
|
436
|
15
|
15
|
5
|
5
|
5
|
5
|
3
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
73
|
81
|
157
|
268
|
480
|
954
|
443
|
436
|
15
|
15
|
5
|
5
|
5
|
5
|
3
|
3
|
3
|
|
| Other Receivables |
30
|
42
|
14
|
21
|
33
|
20
|
18
|
34
|
51
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
23
|
38
|
53
|
112
|
117
|
183
|
121
|
243
|
360
|
367
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
51
|
1 031
|
1 438
|
1 441
|
14
|
15
|
15
|
13
|
13
|
14
|
|
| Total Current Assets |
73
|
107
|
147
|
231
|
492
|
486
|
641
|
1 255
|
875
|
876
|
1 048
|
1 455
|
1 450
|
30
|
25
|
21
|
16
|
16
|
17
|
|
| PP&E Net |
327
|
315
|
309
|
312
|
468
|
522
|
529
|
493
|
530
|
517
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
327
|
315
|
309
|
312
|
468
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
262
|
290
|
318
|
348
|
378
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
24
|
15
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
507
|
453
|
487
|
472
|
443
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
907
N/A
|
876
-3%
|
943
+8%
|
1 015
+8%
|
1 403
+38%
|
1 033
-26%
|
1 185
+15%
|
1 763
+49%
|
1 421
-19%
|
1 417
0%
|
1 048
-26%
|
1 455
+39%
|
1 451
0%
|
31
-98%
|
26
-16%
|
22
-14%
|
16
-28%
|
16
-2%
|
17
+5%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
78
|
32
|
0
|
0
|
0
|
129
|
250
|
843
|
337
|
296
|
31
|
4
|
3
|
4
|
4
|
5
|
0
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
198
|
255
|
328
|
325
|
717
|
334
|
334
|
334
|
334
|
334
|
334
|
334
|
334
|
334
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
159
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
14
|
14
|
81
|
106
|
84
|
151
|
200
|
166
|
155
|
74
|
1 477
|
2 123
|
2 266
|
0
|
0
|
1
|
4
|
2
|
5
|
|
| Total Current Liabilities |
92
|
46
|
81
|
106
|
84
|
478
|
705
|
1 337
|
818
|
1 245
|
1 842
|
2 462
|
2 603
|
339
|
339
|
340
|
338
|
338
|
341
|
|
| Long-Term Debt |
458
|
11
|
44
|
91
|
501
|
205
|
110
|
41
|
174
|
136
|
17
|
17
|
17
|
17
|
17
|
17
|
23
|
30
|
35
|
|
| Other Liabilities |
107
|
0
|
0
|
0
|
0
|
3
|
14
|
16
|
20
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
657
N/A
|
57
-91%
|
125
+118%
|
196
+57%
|
585
+198%
|
686
+17%
|
829
+21%
|
1 393
+68%
|
1 012
-27%
|
1 395
+38%
|
1 859
+33%
|
2 479
+33%
|
2 620
+6%
|
356
-86%
|
356
0%
|
357
+0%
|
361
+1%
|
367
+2%
|
376
+2%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
145
|
818
|
818
|
818
|
818
|
818
|
818
|
818
|
818
|
818
|
788
|
788
|
788
|
788
|
788
|
788
|
788
|
788
|
788
|
|
| Retained Earnings |
1
|
1
|
1
|
1
|
1
|
470
|
461
|
448
|
409
|
796
|
1 599
|
1 812
|
1 957
|
1 113
|
1 118
|
1 123
|
1 164
|
1 140
|
1 147
|
|
| Additional Paid In Capital |
104
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
250
N/A
|
819
+228%
|
819
N/A
|
819
N/A
|
819
N/A
|
347
-58%
|
356
+3%
|
370
+4%
|
409
+11%
|
22
-95%
|
811
N/A
|
1 024
-26%
|
1 170
-14%
|
325
+72%
|
330
-2%
|
335
-2%
|
345
-3%
|
352
-2%
|
359
-2%
|
|
| Total Liabilities & Equity |
907
N/A
|
876
-3%
|
943
+8%
|
1 015
+8%
|
1 403
+38%
|
1 033
-26%
|
1 185
+15%
|
1 763
+49%
|
1 421
-19%
|
1 417
0%
|
1 048
-26%
|
1 455
+39%
|
1 451
0%
|
31
-98%
|
26
-16%
|
22
-14%
|
16
-28%
|
16
-2%
|
17
+5%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
15
|
43
|
43
|
43
|
51
|
51
|
51
|
51
|
51
|
62
|
79
|
79
|
79
|
79
|
79
|
79
|
79
|
79
|
79
|
|
| Preferred Shares Outstanding |
0
|
0
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|